Literature DB >> 33708546

Identification of differentially expressed genes and signaling pathways in papillary thyroid cancer: a study based on integrated microarray and bioinformatics analysis.

Tuanqi Sun1,2, Qing Guan1,2, Yunjun Wang1,2, Kai Qian3, Wenyu Sun2,4, Qinghai Ji1,2, Yi Wu1,2, Kai Guo3, Jun Xiang1,2.   

Abstract

BACKGROUND: The techniques of DNA microarray and bioinformatic analysis have exhibited efficiency in identifying dysregulated gene expression in human cancers. In this study, we used integrated bioinformatics analysis to improve our understanding of the pathogenesis of papillary thyroid cancer (PTC).
METHODS: In this study, we integrated four Gene Expression Omnibus (GEO) datasets, GSE33630, GSE35570, GSE60542 and GSE29265, including 136 normal samples and 157 PTC specimens. The contents of the four datasets are based on GPL570, an Affymetrix Human Genome U133 Plus 2.0 array. Gene ontology (GO) analysis was used to identify characteristic the biological attributes of differentially expressed genes (DEGs) between PTC and normal samples. GO annotation was performed on the DEGs obtained, and the process relied on the DAVID online tool. Kyoto Encyclopedia of Genes and Genomes (KEGG) approach enrichment analyses were adopted to obtain the basic functions of the DEGs. The KOBAS online analysis database was used to complete DEG KEGG pathway comparison and analysis. The search tool (STRING) database was mainly used to search for interacting genes and complete the construction of protein-protein interaction (PPI) networks.
RESULTS: Five hundred-ninety DEGs were consistently expressed in the four datasets; 327 of them were upregulated, while 263 were downregulated. Ten DEGs, including five upregulated (ENTPD1, THRSP, KLK10, ADAMTS9, MIR31HG) and five downregulated (SCARA5, EPHB1, CHRDL1, LOC440934, FOXP2) genes, were randomly selected for q-PCR in our own tissue samples to validate the integrated data. The most highly enriched GO terms were extracellular exosome (GO:0070062), cell adhesion (GO:0070062), positive regulation of gene expression (GO:0010628), and extracellular matrix (ECM) organization (GO:0030198). KEGG pathway analysis was performed, and it was found that abnormally expressed genes effectively participated in pathways such as tyrosine metabolism, complement and coagulation cascades, cell adhesion molecules (CAMs), transcriptional misregulation and ECM-receptor interaction pathways.
CONCLUSIONS: Five hundred-ninety DEGs were identified in PTC by integrated microarray analysis. The GO and KEGG analyses presented here suggest that the DEGs were enriched in extracellular exosome, tyrosine metabolism, CAMs, complement and coagulation cascades, transcriptional misregulation and ECM-receptor interaction pathways. Functional studies of PTC should focus on these pathways. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Differentially expressed genes (DEGs); Gene Expression Omnibus (GEO); biomarkers; papillary thyroid carcinoma (PTC)

Year:  2021        PMID: 33708546      PMCID: PMC7944059          DOI: 10.21037/gs-20-673

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  44 in total

1.  BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.

Authors:  Rossella Elisei; Clara Ugolini; David Viola; Cristiana Lupi; Agnese Biagini; Riccardo Giannini; Cristina Romei; Paolo Miccoli; Aldo Pinchera; Fulvio Basolo
Journal:  J Clin Endocrinol Metab       Date:  2008-08-05       Impact factor: 5.958

2.  BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

Authors:  Mingzhao Xing; William H Westra; Ralph P Tufano; Yoram Cohen; Eli Rosenbaum; Kerry J Rhoden; Kathryn A Carson; Vasily Vasko; Alexandr Larin; Giovanni Tallini; Sara Tolaney; Elizabeth H Holt; Pei Hui; Christopher B Umbricht; Shehzad Basaria; Marge Ewertz; Anthony P Tufaro; Joseph A Califano; Matthew D Ringel; Martha A Zeiger; David Sidransky; Paul W Ladenson
Journal:  J Clin Endocrinol Metab       Date:  2005-09-20       Impact factor: 5.958

Review 3.  Molecular rearrangements in papillary thyroid carcinomas.

Authors:  Horst Zitzelsberger; Verena Bauer; Gerry Thomas; Kristian Unger
Journal:  Clin Chim Acta       Date:  2009-12-01       Impact factor: 3.786

Review 4.  TERT promoter mutations in thyroid cancer.

Authors:  Rengyun Liu; Mingzhao Xing
Journal:  Endocr Relat Cancer       Date:  2016-01-05       Impact factor: 5.678

Review 5.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

6.  Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Authors:  Xiaoguang Shi; Rengyun Liu; Fulvio Basolo; Riccardo Giannini; Xiaopei Shen; Di Teng; Haixia Guan; Zhongyan Shan; Weiping Teng; Thomas J Musholt; Khawla Al-Kuraya; Laura Fugazzola; Carla Colombo; Electron Kebebew; Barbara Jarzab; Agnieszka Czarniecka; Bela Bendlova; Vlasta Sykorova; Manuel Sobrinho-Simões; Paula Soares; Young Kee Shong; Tae Yong Kim; Sonia Cheng; Sylvia L Asa; David Viola; Rossella Elisei; Linwah Yip; Caterina Mian; Federica Vianello; Yangang Wang; Shihua Zhao; Gisele Oler; Janete M Cerutti; Efisio Puxeddu; Shen Qu; Qing Wei; Huixiong Xu; Christine J O'Neill; Mark S Sywak; Roderick Clifton-Bligh; Alfred K Lam; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Hongyu Yu; Giovanni Tallini; Elizabeth H Holt; Vasily Vasko; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2015-11-03       Impact factor: 5.958

7.  Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).

Authors:  Marta Szajnik; Malgorzata Czystowska; Miroslaw J Szczepanski; Magis Mandapathil; Theresa L Whiteside
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

8.  miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.

Authors:  Katarzyna Augoff; Brian McCue; Edward F Plow; Khalid Sossey-Alaoui
Journal:  Mol Cancer       Date:  2012-01-30       Impact factor: 27.401

9.  Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b.

Authors:  H Yang; P Liu; J Zhang; X Peng; Z Lu; S Yu; Y Meng; W-M Tong; J Chen
Journal:  Oncogene       Date:  2015-11-09       Impact factor: 9.867

10.  Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-β/Smad signaling pathway.

Authors:  Jian-Jie Zhao; Shuai Hao; Ling-Li Wang; Chun-Yan Hu; Shu Zhang; Ling-Ji Guo; Gang Zhang; Bo Gao; Yan Jiang; Wu-Guo Tian; Dong-Lin Luo
Journal:  Oncotarget       Date:  2016-09-06
View more
  4 in total

1.  Chordin-Like 1 Regulates Epithelial-to-Mesenchymal Transition and Metastasis via the MAPK Signaling Pathway in Oral Squamous Cell Carcinoma.

Authors:  Qiuyu Wu; Zhichao Zheng; Junwei Zhang; Zhengguo Piao; Mengyu Xin; Xi Xiang; Antong Wu; Tianyu Zhao; Songkai Huang; Yu Qiao; Jiayu Zhou; Shaofen Xu; Haoyu Cheng; Lihong Wu; Kexiong Ouyang
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

2.  FOXP2 regulates thyroid cancer cell proliferation and apoptosis via transcriptional activation of RPS6KA6.

Authors:  Feibiao Yang; Zhangsheng Xiao; Songze Zhang
Journal:  Exp Ther Med       Date:  2022-05-09       Impact factor: 2.751

3.  Suppression of MIR31HG affects the functional properties of thyroid cancer cells depending on the miR-761/MAPK1 axis.

Authors:  Shuwang Peng; Luyang Chen; Zhengtai Yuan; Shanshan Duan
Journal:  BMC Endocr Disord       Date:  2022-04-20       Impact factor: 3.263

4.  The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway.

Authors:  Zhen-Xing Yu; Cheng Xiang; Sheng-Gui Xu; Yang-Ping Zhang
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.